Akkermansia and its metabolites play key roles in the treatment of campylobacteriosis in mice

HIGHLIGHTS

• who: Lai Jiang et al. from the United States Northeast Agricultural University have published the paper: Akkermansia and its metabolites play key roles in the treatment of campylobacteriosis in mice, in the Journal: (JOURNAL)
• what: The study shows that FMT can effectively treat high-dose C. jejuni infection. The study demonstrates that butyric acid has good therapeutic efficacy against C. jejuni infection in mice, and some studies have also shown that butyric acid promotes the antibacterial activity of intestinal macrophages in_vivo, limits cell translocation in_vivo and protects mice from C. difficileinduced colitis through a HIF . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.